Dr. Nabors on Evolving Treatment Options for Brain Metastases

Louis B. Nabors, MD
Published: Friday, Mar 22, 2019



Louis B. Nabors, MD, professor, University of Alabama, Birmingham Comprehensive Cancer Center, discusses the evolving treatment landscape for patients with brain metastases. For decades, as treatment for patients with brain metastases, physicians mainly relied on neurosurgery and radiation, and there were limited systemic therapy options.

Today, there is an increasing amount of systemic therapy options, says Nabors. These therapies have clearly demonstrated activity in metastatic disease in the central nervous system, he adds.

Research continues to focus on further developing these opportunities to better understand how to deploy systemic therapies in these patients. This will be a major goal over the next several years, he concludes.

<<< 2019 NCCN Annual Meeting


Louis B. Nabors, MD, professor, University of Alabama, Birmingham Comprehensive Cancer Center, discusses the evolving treatment landscape for patients with brain metastases. For decades, as treatment for patients with brain metastases, physicians mainly relied on neurosurgery and radiation, and there were limited systemic therapy options.

Today, there is an increasing amount of systemic therapy options, says Nabors. These therapies have clearly demonstrated activity in metastatic disease in the central nervous system, he adds.

Research continues to focus on further developing these opportunities to better understand how to deploy systemic therapies in these patients. This will be a major goal over the next several years, he concludes.

<<< 2019 NCCN Annual Meeting



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication
x